首页> 中文期刊> 《中国中医药现代远程教育》 >中医药治疗阿尔茨海默病APP/PS1双转基因小鼠的研究进展

中医药治疗阿尔茨海默病APP/PS1双转基因小鼠的研究进展

         

摘要

中医药在治疗阿尔茨海默病方面具有多靶点、多方式、多途径的优势.目前,APP/PSI双转基因小鼠是一种比较理想的能反映AD特征的AD动物模型,且该模型已成功应用于中医药防治AD的领域.本文结合该领域的最新研究进展,对近年来中药复方及有效成分治疗阿尔茨海默病APP/PSI双转基因小鼠进行综述.%Traditional Chinese medicine has the advantages of multi-target, multi-modal and multi-path in the treatment of Alzheimer's disease. At present, APP/PSI double transgenic mouse is an ideal animal model of AD that can reflect the characteristics of AD, and the model has been successfully applied in the field of Chinese medicine in the prevention and treatment of AD. In this paper, the latest research advances in this field, review the recent years, Chinese medicine compound and active ingredients in the treatment of Alzheimer's disease APP/PS1 double transgenic mice.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号